Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stents: A Meta-Analysis

The Scientific World Journal - Egypt
doi 10.1155/2014/794078
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Risk of Non-Cardiac Surgery After Percutaneous Coronary Intervention With Drug-Eluting Stents

Scientific Reports
Multidisciplinary
2017English

Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Drug-Eluting Stents

Anesthesiology
AnesthesiologyPain Medicine
2008English

Duration of Dual Antiplatelet Therapy in Patients Treated With Percutaneous Coronary Intervention for Coronary Chronic Total Occlusion

PLoS ONE
Multidisciplinary
2017English

Triple Versus Dual Antiplatelet Therapy for Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2013English

Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Should Dual Antiplatelet Therapy After Drug-Eluting Stents Be Continued for More Than 1 Year?: Dual Antiplatelet Therapy After Drug-Eluting Stents Should Be Continued for More Than One Year and Preferably Indefinitely

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2008English

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2019English

Head-To-Head Comparison of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies

PLoS ONE
Multidisciplinary
2014English

Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention

JAMA - Journal of the American Medical Association
Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy